ArticleFrontiers in psychiatry2025
Temperament correlates of stigma resistance among patients with mood disorders: a cross-sectional study.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In the realm of mental health, stigma presents a barrier to well-being and social acceptance. However, amidst societal prejudices, stigma resistance emerges as a vital concept, reflecting individuals' capacity to challenge negative stereotypes and maintain a positive self-concept. This paper explores the dynamics of stigma resistance, its determinants, and its implications for mental health outcomes, focusing specifically on mood disorder patients. Methods: Adult patients with mood disorders who provided written informed consent were consecutively recruited. Data were collected between 2020 and 2022 at the Mood Disorder Unit of the Geneva University Hospitals. Participants were assessed using the Mini International Neuropsychiatric Interview (MINI), Montgomery-Åsberg Depression Rating Scale (MADRS), Young Mania Rating Scale (YMRS), Internalized Stigma of Mental Illness scale (ISMI), Temperament Evaluation of Memphis, Pisa, Paris and San Diego Autoquestionnaire (TEMPS-A), and the Quality of Life in Bipolar Disorder scale (QolBD). For all scales, higher scores indicate greater symptom severity or higher levels of the measured construct. Results: In this sample, the majority of patients were women, approximately one-third were single, and about half had completed high school or university education. Most participants were well integrated in the labor market. Multiple linear regression analyses indicated that shorter illness duration, higher hyperthymic temperament scores, and better quality of life were significantly associated with greater stigma resistance. Additionally, a positive trend was observed between internalized stigma and stigma resistance, although this did not reach statistical significance. Conclusions: Our study highlights the complex interplay of factors influencing stigma resistance among individuals with mood disorders. Understanding these dynamics is crucial for developing targeted interventions to enhance resilience and improve outcomes in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.